Despite all the knowing smiles and sly digs about cannabis, there's nothing flippant about Cannasouth chief executive Mark Lucas.

When it comes to cannabis for medicinal use, he's deadly serious.

And he talks passionately about the drug's potential for people who suffer from seizures, or for those with terminal illnesses.

Lucas says the day may come when demand for medicinal cannabis is greater than the demand from recreational users.


For NZX-listed Cannasouth, it has been a battle of perceptions about cannabis, particularly since it is THC — the part of the plant that provides the high — that tends to


No time to wait

Tilray and Trojan horses

Quest for consistency

Beating the stigma

Long road ahead

Rewriting the law